592
29
8
3
86
Cat. No. | Product Name | ||
---|---|---|---|
L3400 | 临床期小分子药物库 | 3404 compounds | |
3404 个临床期化合物集合,可用于高通量筛选和高内涵筛选; | |||
L2193 | 抗肝癌化合物库 | 1787 compounds | |
1787 种与肝癌相关的化合物,可以用于抗肝癌药物研发和药理研究; | |||
L2192 | 抗胰腺癌化合物库 | 2238 compounds | |
2238 种与胰腺癌相关的化合物,可以用于高通量和高内涵筛选; | |||
L2194 | 抗结直肠癌化合物库 | 1545 compounds | |
1545 种与结直肠癌相关的化合物,可以用于高通量和高内涵筛选; | |||
L2191 | 抗乳腺癌化合物库 | 1939 compounds | |
1939 种与乳腺癌相关的化合物,可以用于抗乳腺癌药物研发和药理研究; | |||
L1610 | FDA 上市激酶抑制剂库 | 263 compounds | |
263种靶向激酶的上市药物集合,用于特定靶向激酶,可用于高通量筛选和高内涵筛选; | |||
L1600 | 激酶抑制剂库 | 2720 compounds | |
2720 种激酶抑制剂/调节剂的独特集合,用于特定靶向激酶,可用于高通量筛选和高内涵筛选; | |||
L9410 | 共价抑制剂库 | 1920 compounds | |
1920 种小分子的独特集合,包含已发现的共价抑制剂以及包含某些共价反应基团常见弹头的分子,如氯乙酰基,2-氯丙酰基,丙烯酰基,1-丙-2-炔基,1-丁-2-炔基,酮羰基,二硫键等,可以用于共价抑制剂药物研发; |
Cat. No. | Product Name | Form | Specificity Of Inhibition |
---|---|---|---|
CL0058 |
EGFR inhibitor kit
EGFR inhibitor kit |
||
CL0068 |
VEGFR inhibitor kit
VEGFR inhibitor kit |
||
CL0085 |
HSP inhibitor kit
HSP inhibitor kit |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T5168 |
EGFR-IN-12
EGFR Inhibitor |
Apoptosis; EGFR | Angiogenesis; Apoptosis; JAK/STAT signaling; Tyrosine Kinase/Adaptors |
EGFR-IN-12 (EGFR Inhibitor) 是一种 4,6-二取代的嘧啶,可诱导细胞凋亡,具有抗肿瘤活性。它是ATP 竞争性,不可逆且高度选择性的EGFR 抑制剂,IC50为 21 nM。它对EGFR 的选择性高于 HER4 和 55种其他激酶。它还抑制突变型EGFRL858R 和EGFRL861Q,IC50分别为 63 nM 和 4 nM。 | |||
T21954 |
EGFR/ErbB-2/ErbB-4 inhibitor-2
EGFR/ErbB2 Inhibitor |
EGFR | Angiogenesis; JAK/STAT signaling; Tyrosine Kinase/Adaptors |
EGFR/ErbB-2/ErbB-4 inhibitor-2 (EGFR/ErbB2 Inhibitor) 是EGFR 和ErbB 的抑制剂,对EGFR、ErbB2 和 ErbB4 的IC50分别为 0.017、0.08 和 1.91 μM。 | |||
T11163 |
EGFR-IN-9
|
EGFR | Angiogenesis; JAK/STAT signaling; Tyrosine Kinase/Adaptors |
EGFR-IN-9 是一种有效的 EGFR 激酶抑制剂,对于野生型 EGFR 激酶和双重突变型 EGFR 激酶 (L858R/T790M) 的 IC50 分别为 7 nM 和 28 nM。EGFR-IN-9 具有抗肿瘤活性。 | |||
T2705 |
Mutant EGFR inhibitor
|
EGFR | Angiogenesis; JAK/STAT signaling; Tyrosine Kinase/Adaptors |
Mutant EGFR inhibitor 是选择性EGFR 突变体抑制剂,可抑制EGFRL858R、EGFRExon 19 deletion 和EGFRT790M。 | |||
T11162 |
EGFR-IN-8
|
EGFR; c-Met/HGFR | Angiogenesis; JAK/STAT signaling; Tyrosine Kinase/Adaptors |
EGFR-IN-8 是 EGFR 和 c-Met 的双重抑制剂。 EGFR-IN-8可用于靶向 EGFR TKI 耐药的 NSCLC 的研究。 | |||
T11158 |
EGFR-IN-11
|
EGFR | Angiogenesis; JAK/STAT signaling; Tyrosine Kinase/Adaptors |
EGFR-IN-11 是 EGFR-酪氨酸激酶的选择性抑制剂,可诱导细胞凋亡。 EGFR-IN-11 抑制三重突变体 EGFRL858R/T790M/C797S,IC50 为 18 nM,并在 G0/G1 时阻止细胞周期。 | |||
T10802 |
CHMFL-EGFR-202
|
EGFR | Angiogenesis; JAK/STAT signaling; Tyrosine Kinase/Adaptors |
CHMFL-EGFR-202 是一种有效、不可逆的表皮生长因子受体 (EGFR) 突变型激酶抑制剂, 对耐药突变型 EGFR T790M 和 WT EGFR 激酶作用的 IC50 分别为 5.3 nM 和 8.3 nM。 | |||
T11157L |
EGFR-IN-1 hydrochloride
|
EGFR | Angiogenesis; JAK/STAT signaling; Tyrosine Kinase/Adaptors |
EGFR-IN-1 hydrochloride 是 L858R/T790M 突变体 EGFR 的不可逆特异性抑制剂,选择性是野生型 EGFR 的 100 倍。 EGFR-IN-1 hydrochloride 在 H1975 细胞和突变体 HCC827 细胞中表现出有效的抗肿瘤和抗增殖活性,IC50 分别为 4 和 28 nM。 | |||
T11160 |
EGFR-IN-5
|
EGFR | Angiogenesis; JAK/STAT signaling; Tyrosine Kinase/Adaptors |
EGFR-IN-5 是 EGFR 的特异性抑制剂。 EGFR、EGFR(L858R)、EGFR(L858R/T790M) 和 EGFR(L858R/T790M/C797S) 的 IC50 分别为 10.4、1.1、34、7.2 nM。 | |||
T11161 |
EGFR-IN-7
TQB3804 |
EGFR | Angiogenesis; JAK/STAT signaling; Tyrosine Kinase/Adaptors |
EGFR-IN-7 (TQB3804) 是一种有效选择性的EGFR 激酶抑制剂,对 EGFR (WT) 和 EGFR (mutant C797S/T790M/L858R) 的IC50值分别为 7.92 和 0.218 nM,具有抗肿瘤活性。 | |||
T16162 |
Mutated EGFR-IN-1
Osimertinib analog,AZD9291中间体1 |
EGFR | Angiogenesis; JAK/STAT signaling; Tyrosine Kinase/Adaptors |
Mutated EGFR-IN-1 (Osimertinib analog) 是用于突变 EGFR 抑制剂设计的有用中间体,例如 L858R EGFR、Exon19 缺失激活突变体和 T790M 抗性突变体。 | |||
T79888 |
EGFR-IN-87
|
EGFR | Angiogenesis; JAK/STAT signaling; Tyrosine Kinase/Adaptors |
EGFR-IN-87 为EGFR酪氨酸激酶抑制剂,针对A431细胞中EGFR_d746-750, EGFR_L858R/T790M 及 EGFR_WT 具有IC50值分别约为3.1 nM、1.3 nM和7.1 nM,适用于癌症疾病研究。 | |||
T63732 |
EGFR-IN-3
|
Apoptosis; EGFR | Angiogenesis; Apoptosis; JAK/STAT signaling; Tyrosine Kinase/Adaptors |
EGFR-IN-3 是一种 EGFR 抑制剂,具有潜在的抗肿瘤活性。EGFR-IN-3 抑制 EGFRwt-TK,诱导细胞凋亡 (apoptosis),可使细胞在G2/M期阻滞。 | |||
TP1613 |
[pTyr5] EGFR (988-993)
[pTyr5] EGFR 988-993 |
||
[pTyr5] EGFR (988-993) is a compound obtained from the auto-phosphorylation site, Tyr992, located within the sequence of the epidermal growth factor receptor (EGFR 988-993). This compound is frequently found bound with the catalytically inactive protein-tyrosine phosphate 1B (PTP1B). | |||
TQ0255 |
Olafertinib
CK-101,EGFR-IN-3,RX-518 |
EGFR | Angiogenesis; JAK/STAT signaling; Tyrosine Kinase/Adaptors |
Olafertinib (RX-518) 是新型突变选择性、不可逆、可口服的EGFR 酪氨酸酶抑制剂,可克服 NSCLC 中 T790M 介导的耐药性。 | |||
T75120 |
EGFR-IN-76
|
EGFR | Angiogenesis; JAK/STAT signaling; Tyrosine Kinase/Adaptors |
EGFR-IN-76 是 一种有有效的 EGFR 抑制剂。 | |||
T35901 |
EGFR-IN-99
JBJ-03-142-02 |
EGFR; HER | Angiogenesis; JAK/STAT signaling; Tyrosine Kinase/Adaptors |
EGFR-IN-99 (JBJ-03-142-02) 是一种 EGFR 和 HER2 Exon 20 插入突变抑制剂,具有抗增殖活性,可用于研究非小细胞肺癌 (NSCLC) 。 | |||
T9905 |
Cetuximab
Cetuximab (anti-EGFR),C225,西妥昔单抗 |
EGFR | Angiogenesis; JAK/STAT signaling; Tyrosine Kinase/Adaptors |
Cetuximab (C225) 属于单克隆抗体,是一种人源表皮生长因子受体 (EGFR) 的抑制剂 (Kd=0.201 nM)。Cetuximab 具有抗肿瘤活性,可以抑制肿瘤细胞增殖,诱导细胞凋亡。 | |||
T40209 | EGFR-IN-15 | ||
EGFR-IN-15 (compound I-005) is a potent EGFR inhibitor, exhibiting an IC50 value of 4 nM. This compound holds potential for oncological research applications. | |||
T79861 |
EGFR/ErbB-2 inhibitor-1
|
EGFR | Angiogenesis; JAK/STAT signaling; Tyrosine Kinase/Adaptors |
EGFR/ErbB-2 inhibitor-1 是一种选择性的 ErbB2/HER2 抑制剂,能有效地阻断ErbB2和HER2的信号传导。 | |||
T27247 | EGFR-IN-542 | ||
EGFR-IN-542 is a novel EGFR inhibitor. EGFR-IN-542 significantly reduces myocardial inflammation, fibrosis, apoptosis and dysfunction. It shows promise for use in the treatment of obesity-induced cardiac complications. | |||
T11157 |
EGFR-IN-1
|
EGFR | Angiogenesis; JAK/STAT signaling; Tyrosine Kinase/Adaptors |
EGFR-IN-1, an orally active and irreversible selective inhibitor targeting L858R/T790M mutant EGFR, exhibits strong antiproliferative and antitumor activity, particularly against H1975 cells and first line mutant HCC827 cells. This compound potently inhibits Gefitinib-resistant EGFR L858R/T790M mutations with a 100-fold selectivity over the wild-type EGFR. | |||
T41099 |
EGFR Protein Tyrosine Kinase Substrate
|
||
EGFR Protein Tyrosine Kinase Substrate is a EGFR protein tyrosine kinase substrate. | |||
T11164 |
EGFR mutant-IN-1
|
EGFR | Angiogenesis; JAK/STAT signaling; Tyrosine Kinase/Adaptors |
EGFR mutant- in-1, A 5-methylpyrimidopyridone derivative are effective selective EGFRL858R/T790M/C797S mutant inhibitors with IC50 of 27.5 nM, which significantly weakened EGFRWT effect. | |||
T11159 |
EGFR-IN-2
|
EGFR | Angiogenesis; JAK/STAT signaling; Tyrosine Kinase/Adaptors |
EGFR-IN-2 is a non-covalent, mutation-selective and irreversible second-generation EGFR inhibitor. | |||
T69807 |
EGFR-IN-451
|
||
EGFR-IN-451 is an EGFR inhibitor, attenuating Ang II-induced Kidney Fibrosis. | |||
T8525 |
EGFR-IN-16
AG473 |
EGFR; FGFR | Angiogenesis; JAK/STAT signaling; Tyrosine Kinase/Adaptors |
EGFR-IN-16 (AG473) 是一种EGFR 抑制剂,对 EGFR 和 HER-2 的pIC50分别为4.85和4.74。 | |||
T12131 |
Mutated EGFR-IN-3
|
EGFR | Angiogenesis; JAK/STAT signaling; Tyrosine Kinase/Adaptors |
Mutated EGFR-IN-3 is a ATP-competitive and highly selective allosteric dibenzodiazepinone EGFR(L858R/T790M) and EGFR(L858R/T790M/C797S) inhibitor(IC50 of 12 nM and 13 nM, respectively. ) | |||
T12130 |
Mutated EGFR-IN-2
|
EGFR | Angiogenesis; JAK/STAT signaling; Tyrosine Kinase/Adaptors |
Mutated EGFR-IN-2 is an inhibitor of mutant-selective EGFR. | |||
T73154 |
EGFR-IN-70
|
||
EGFR-IN-70 是一种有效的EGFR 抑制剂,对于EGFRLR/TM/CS 和EGFRWT,其IC50值分别为 23.6 和 307.5 nM。EGFR-IN-70 具有抗增殖活性并抑制EGFR 的磷酸化。EGFR-IN-70 可用于癌症研究。 | |||
T62009 |
EGFR-IN-71
|
||
EGFR-IN-71 是有效的表皮生长因子受体 (EGFR)抑制剂(IC50= 3.7 μM)。EGFR-IN-71 在脊索瘤中具有研究价值。 | |||
T73178 | EGFR-IN-75 | ||
EGFR-IN-75 是一种EGFRWT 和EGFRT790M 抑制剂,IC50值分别为 0.28 μM 和 5.02 μM。EGFR-IN-75 具有抗癌和抗氧化活性。 | |||
T78574 | EGFR-IN-85 | EGFR | Angiogenesis; JAK/STAT signaling; Tyrosine Kinase/Adaptors |
EGFR-IN-85(Compound 1)为EGFR抑制剂,对EGFRvⅢ磷酸化具有0.19 μM的IC50。本化合物可抑制肿瘤内EGFR信号传导,适用于恶性胶质瘤(GBM)研究。 | |||
T62457 |
EGFR-IN-54
|
||
EGFR-IN-54 (Compound 3c) 是一种 EGFR 的有效抑制剂 (IC50: 1.623 μM),对癌细胞具有毒性。 | |||
T63556 | EGFR-IN-59 | ||
EGFR-IN-59 是 EGFR 抑制剂,其IC50值为190 nM,也是一直凋亡 (apoptosis) 诱导剂。EGFR-IN-59 对非小肺癌细胞系 (A549) 和正常肺成纤维细胞 (WI38) 表现出细胞毒性的IC50分别为 8.62 和 52.6 μM。EGFR-IN-59 能够用于研究非小细胞肺癌 (NSCLC)、头颈癌、乳腺癌和结直肠癌等多种癌症。 | |||
T64255 | EGFR-IN-48 | ||
EGFR-IN-48 是一种有效的、口服具有活力的 EGFR 抑制剂,能够作用于 EGFRd19/TM/CS (IC50: 0.193 nM)、EGFRLR/TM/CS (IC50: 0.251 nM)、EGFRWT (IC50: 10.4 nM)。EGFR-IN-48 也能够抑制 BaF3EGFR del19/T790M/C797S 细胞 (IC50: 1.526 nM) 和 PC-9EGFR del19/T790M/C797S 细胞 (IC50: 66.7 nM)的增殖。 | |||
T79386 |
EGFR-IN-84
|
EGFR | Angiogenesis; JAK/STAT signaling; Tyrosine Kinase/Adaptors |
EGFR-IN-84 (Compound 6g),作为EGFR抑制剂(IC50: 24 nM),对A549细胞生长表现出抑制作用(IC50: 1.537 μM),适用于肺癌研究。 | |||
T64020 |
EGFR-IN-17
|
||
EGFR-IN-17 是有效的、选择性的表皮生长因子受体(EGFR)抑制剂,其 IC50 值为0.0002 μM,能够用于克服 C797S 介导的耐药性。 | |||
T61696 | EGFR-IN-57 | ||
EGFR-IN-57 (Compound 25a) 是一种有效的、具有口服活性的EGFR-TK 抑制剂,IC50值为 0.054 μM。EGFR-IN-57 也抑制VEGFR-2、CK2α、topoisomerase IIβ和tubulin polymerization,IC50值分别为 0.087、0.171、0.13 和 3.61 μM。EGFR-IN-57 诱导细胞 G2/M 和 pre-G1 期周期阻滞,诱导癌细胞凋亡 (apoptosis)。 | |||
T75261 | EGFR-IN-1 TFA | ||
EGFR-IN-1 TFA 是一种口服活性不可逆的突变型选择性 L858R/T790MEGFR 抑制剂。与野生型 EGFR 相比,EGFR-IN-1 TFA 对 Gefitinib 耐药的 EGFRL858R/T790M 有 100 倍的抑制作用。EGFR-IN-1 TFA 对 H1975 细胞和 HCC827 细胞具有较强的抗增殖活性。具有抗肿瘤活性。 | |||
T76697 | Panitumumab (anti-EGFR) | ||
Panitumumab (anti-EGFR) 是一种全人源IgG2抗EGFR 单克隆抗体,具有抗肿瘤活性。Panitumumab (anti-EGFR) 抑制肿瘤细胞增殖、存活和血管生成。Panitumumab (anti-EGFR) 可用于癌症研究,例如结肠癌。 | |||
T63996 |
EGFR-IN-50
|
||
EGFR-IN-50 是一种针对 L858R 抗性突变的强效 EGFR 抑制剂,能够作用于 TEL-EGFR-L858R-BaF3 及 TEL-EGFR-T790M-L858R-BaF3,他们的 GI50 值分别为 8 nM、6.03 μM。EGFR-IN-50 对癌细胞表现出抗增殖作用。 | |||
T63774 | EGFR-IN-58 | ||
EGFR-IN-58 是一种有效的、选择性的、 ATP 竞争性的 EGFR 抑制剂。EGFR-IN-58 对黑色素瘤、结肠癌和血癌表现出显著的细胞毒性。 | |||
T74215 |
EGFR-IN-22
|
||
EGFR-IN-22 是一种有效的 EGFR 抑制剂,对野生型 EGFR 和 EGFRL858R/T790M/C797S 的 IC50分别为 4.91 nM 和 0.54 nM。 | |||
T63178 |
EGFR-IN-39
|
||
EGFR-IN-39 是一种丙烯酰胺衍生物,是一种 EGFR 的有效抑制剂。EGFR-IN-39 是一种低毒副作用的抗肿瘤药物。其中表皮生长因子受体 (EGFR) 的过度表达和突变已被明确证实会造成细胞生长无法控制,且与大多数癌症疾病(尤其是 NSCLC)的进展有关。EGFR-IN-33 具有潜力进行 EGFR 突变相关疾病的研究。 | |||
T63264 |
EGFR-IN-33
|
||
EGFR-IN-33 是一种丙烯酰胺衍生物,是低毒副作用的抗肿瘤药物,是 EGFR 的有效抑制剂。其中表皮生长因子受体 (EGFR) 的过度表达和突变已被证实会导致细胞无节制的生长,并与大多数癌症疾病,尤其是 NSCLC 的进展有关。EGFR-IN-33 表现出 EGFR 突变相关疾病的研究潜力。 | |||
T63283 |
EGFR-IN-38
|
||
EGFR-IN-38 是一种低毒副作用的、丙烯酰胺衍生物的抗肿瘤药物,是 EGFR 的有效抑制剂。其中表皮生长因子受体 (EGFR) 的过度表达和突变已被证实会导致细胞无节制的生长,并与大多数癌症疾病,尤其是 NSCLC 的进展有关。EGFR-IN-38 表现出 EGFR 突变相关疾病的研究潜力。 | |||
T62458 |
EGFR-IN-56
|
||
EGFR-IN-56 (Compound 13a) 是一种 EGFR 的有效抑制剂,能够作用于 EGFRT790M (IC50: 541.7 nM) 和 EGFRT790M/L858R (IC50: 132.1 nM)。EGFR-IN-56 能够将癌细胞的细胞周期阻滞在 G2/M 期,并诱导细胞凋亡 (apoptosis)。 | |||
T78788 | EGFR-IN-82 | EGFR | Angiogenesis; JAK/STAT signaling; Tyrosine Kinase/Adaptors |
EGFR-IN-82(化合物8a)是一种口服活性的EGFR抑制剂,显示出对EGFRL858R/T790M/C797S的IC50为0.09 nM,以及对EGFRDel19/T790M/C797S的IC50为0.06 nM的高选择性,而对EGFRWT的抑制作用不明显。此化合物具备显著的抗增殖能力,并能有效抑制肿瘤增长,常用于非小细胞肺癌(NSCLC)的研究。 | |||
T63784 | EGFR-IN-44 | ||
EGFR-IN-44 是有效的、口服具有活力的 EGFRtyrosine kinase 抑制剂 (IC50: 4.11 nM)。EGFR-IN-44 口服生物利用度为33.57%,能够诱导细胞凋亡 (apoptosis)。EGFR-IN-44 能够用于研究非小细胞肺癌。 |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T1181 |
Gefitinib
ZD1839,吉非替尼 |
EGFR; Tyrosine Kinases; Autophagy | Angiogenesis; Autophagy; JAK/STAT signaling; Tyrosine Kinase/Adaptors |
Gefitinib (ZD1839) 是一种 EGFR 一代抑制剂,具有口服活性,抑制 EGFR 19 Del 和 L858R 突变。Gefitinib 具有抗肿瘤活性,用于治疗 EGFR 突变的非小细胞肺癌。Gefitinib 用药会产生 EGFR C797S 耐药突变。 | |||
T3870 |
Cyasterone
杯苋甾酮,Cyasteron |
Apoptosis; EGFR | Angiogenesis; Apoptosis; JAK/STAT signaling; Tyrosine Kinase/Adaptors |
Cyasterone (Cyasteron) 是主要分离自金疮小草的一种天然 EGFR 抑制剂。它通过诱导细胞凋亡和细胞周期阻滞表现出抗增殖作用,可用于抗人类肿瘤的相关研究。 | |||
TL0016 |
Sulforaphene
油菜 |
Apoptosis; ERK; EGFR; NF-κB | Angiogenesis; Apoptosis; JAK/STAT signaling; MAPK; NF-κB; Tyrosine Kinase/Adaptors |
Sulforaphene 是从萝卜种子中分离出来的天然产物,对鹿茸幼苗的 ED50 约为 2 x 10 -4 M。它通过抑制 EGFR、p-ERK1/2、NF-κB 和其他信号促进癌细胞凋亡并抑制迁移。 | |||
T22974 |
Methyl 2,5-dihydroxycinnamate
|
EGFR | Angiogenesis; JAK/STAT signaling; Tyrosine Kinase/Adaptors |
Methyl 2,5-dihydroxycinnamate 是 erbstatin 类似物,是一种高效、稳定的 EGF 受体相关酪氨酸激酶的抑制剂。 | |||
T1431 |
Khellin
凯林,Amicardine,Methafrone,Visammin |
EGFR; Others | Angiogenesis; JAK/STAT signaling; Others; Tyrosine Kinase/Adaptors |
Khellin (Methafrone) 是从阿米芹中提取得到的一种呋喃并色酮,是EGFR 抑制剂,IC50为 0.15 µM。它体外具有抗增殖活性,还具有抗痉挛和冠状动脉舒张作用。 | |||
T2995 |
Chrysophanol
大黄酚,3-Methylchrysazin,Chrysophanic Acid,Turkey Rhubarb |
EGFR | Angiogenesis; JAK/STAT signaling; Tyrosine Kinase/Adaptors |
Chrysophanol (Turkey Rhubarb) 是掌叶大黄中的一种蒽醌类天然产物,可抑制EGF-诱导的EGFR 磷酸化,且抑制AKT 和mTOR/p70S6K 激活。 | |||
T1737 |
Genistein
NPI 031L,三叶草,染料木素,金雀异黄酮 |
Apoptosis; EGFR; Endogenous Metabolite; Autophagy | Angiogenesis; Apoptosis; Autophagy; JAK/STAT signaling; Metabolism; Tyrosine Kinase/Adaptors |
Genistein (NPI 031L) 是一种大豆异黄酮,是一种多重的酪氨酸激酶抑制剂,通过改变细胞凋亡,细胞周期和血管生成以及抑制转移对多种癌症有化疗作用。 | |||
T0683 |
Mevastatin
Compactin,ML236B,美伐他汀 |
Apoptosis; Antibacterial; Antibiotic; HMG-CoA Reductase; Autophagy; Lipid | Apoptosis; Autophagy; Metabolism; Microbiology/Virology |
Mevastatin (ML236B) 是他汀类 HMG-CoA 还原酶抑制剂。它是一种降脂药,可诱导细胞凋亡,将癌细胞阻滞在 G0/G1期。它还可增加内皮型一氧化氮合酶的 mRNA 和蛋白质水平。它有抗肿瘤活性,用于心血管疾病的研究。 | |||
T6427 |
Butein
2’,3,4,4’-tetrahydroxy Chalcone,紫铆因 |
Apoptosis; EGFR; Others; PDE; Autophagy | Angiogenesis; Apoptosis; Autophagy; JAK/STAT signaling; Metabolism; Others; Tyrosine Kinase/Adaptors |
Butein (2’,3,4,4’-tetrahydroxy Chalcone) 是一种 cAMP 特异性PDE 抑制剂,也是蛋白酪氨酸激酶抑制剂,还是一种SIRT1激活剂。它通过 AKT 和 ERK/p38 MAPK 通路,靶向 FoxO3a 使 HeLa 细胞对 Cisplatin 敏感。 | |||
T2851 |
Daphnetin
7,8-Dihydroxycoumarin,Daphnetol,瑞香素 |
EGFR; PKA; PKC; Parasite; Autophagy | Angiogenesis; Autophagy; Chromatin/Epigenetic; Cytoskeletal Signaling; JAK/STAT signaling; Microbiology/Virology; Tyrosine Kinase/Adaptors |
Daphnetin (7,8-Dihydroxycoumarin) 是从 Genus Daphne 中分离得到的香豆素衍生物,有抗氧化、抗炎、抗疟疾和解热作用,可用于凝血功能障碍、类风湿性关节炎等疾病的相关研究。 | |||
TN1440 |
Beta-Hydroxyisovalerylshikonin
|
EGFR; Tyrosine Kinases; Prostaglandin Receptor; Src; AMPK; Fatty Acid Synthase | Angiogenesis; Chromatin/Epigenetic; GPCR/G Protein; Immunology/Inflammation; JAK/STAT signaling; Metabolism; PI3K/Akt/mTOR signaling; Tyrosine Kinase/Adaptors |
Beta-hydroxyisovalerylshikonin 是分离自Lithospermium radix 的天然产物,具有抑制PTK 的作用, 对 EGFR 和 v-Src 受体作用的IC50分别为 0.7 μM 和 1 μM。它对多种肿瘤细胞系均有抑制作用,可以高效诱导 NCI-H522 和 DMS114 细胞的死亡。 | |||
T4183 |
lavendustin A
RG-14355,NSC 678027,薰草菌素 |
EGFR; Tyrosinase | Angiogenesis; JAK/STAT signaling; Proteases/Proteasome; Tyrosine Kinase/Adaptors |
lavendustin A (RG-14355) 是从链霉菌中分离得到的一种天然产物,是细胞渗透性表皮生长因子受体 (EGFR) 酪氨酸激酶抑制剂,能抑制血管内皮生长因子诱导的血管生成,阻断 LTPGABA-A 的诱导。 | |||
T4S0544 |
Furanodienone
呋喃二烯酮,莪术呋喃二烯酮 |
Apoptosis; HER | Angiogenesis; Apoptosis; JAK/STAT signaling; Tyrosine Kinase/Adaptors |
Furanodienone 是来源于姜黄根茎的一种主要生物活性成分,可诱导细胞凋亡。 | |||
T2894 |
Norcantharidin
Norcantharadine,去甲斑蝥素,Endothall anhydride |
EGFR; c-Met/HGFR | Angiogenesis; JAK/STAT signaling; Tyrosine Kinase/Adaptors |
Norcantharidin (Norcantharadine) 是一种合成的抗癌化合物,是人类结肠癌中 c-Met 和 EGFR 的双重抑制剂。 | |||
TN2309 |
Withanolide A
|
EGFR; TNF; NF-κB | Angiogenesis; Apoptosis; JAK/STAT signaling; NF-κB; Tyrosine Kinase/Adaptors |
Withanolide A 提取于印度草药 Ashwagandha 中,在严重受损的神经元中,能再生神经元突并重建突触。它延长了人类 EGFR 驱动的癌性秀丽隐杆线虫的寿命。 | |||
T5656 |
(±)-Norcantharidin
Endothall anhydride,去甲斑蝥素,Norcantharidin |
EGFR; c-Met/HGFR | Angiogenesis; JAK/STAT signaling; Tyrosine Kinase/Adaptors |
(±)-Norcantharidin (Endothall anhydride) 是一种人类结肠癌中 c-Met 和 EGFR 的双重抑制剂,可研究抗癌,具有抗血管生成活性。 | |||
TN5254 |
Wighteone
Erythrinin B,6-Isopentenylgenistein |
Antifungal | Microbiology/Virology |
Wighteone (Erythrinin B) 是一种从 Genista ephedroides 中提取出来的小分子化合物,具有潜在的抗真菌和抗癌活性,对 EGFR L858R/T790M 突变非小细胞肺癌具有抗肿瘤作用。。 | |||
TN1564 |
Delphinidin 3-glucoside chloride
Delphinidin-3-O-glucoside chloride |
Apoptosis; EGFR | Angiogenesis; Apoptosis; JAK/STAT signaling; Tyrosine Kinase/Adaptors |
Delphinidin 3-glucoside chloride (Delphinidin-3-O-glucoside chloride) 是从 Hibiscus sabdariffa 提取物中发现的膳食酚类物质。Delphinidin 3-glucoside chloride 具有抗氧化活性,可诱导 B 细胞慢性淋巴细胞性白血病 (B CLL) 的促凋亡作用,抑制 EGFR,抑制血小板聚集。Delphinidin 3-glucoside chloride 具有抗肿瘤活性,通过调节 pAKT/IRF1/HOTAIR 通路发挥作用。 | |||
T36715 |
Tetrac
Tetraiodothyroacetic acid,3,3',5,5'-Tetraiodothyroacetic acid |
Apoptosis; EGFR | Angiogenesis; Apoptosis; JAK/STAT signaling; Tyrosine Kinase/Adaptors |
Tetrac (Tetraiodothyroacetic acid)是L-甲状腺素(T4)的衍生物,是一种甲状腺整合素受体拮抗剂。Tetrac通过阻断EGFR介导的结直肠癌细胞信号传导来诱导抗增殖。Tetrac 可阻断 T4 和 3,5,3'-triiodo-L-thyronine (T3)在细胞表面甲状腺素整合素 αvβ3 受体上的作用。Tetra 具有抗血管生成、抗肿瘤活性和促凋亡活性。 | |||
TJS0339 |
Coumarin-3-carboxylic acid
香豆素-3-羧酸,3-Carboxycoumarin |
VEGFR | Angiogenesis; Tyrosine Kinase/Adaptors |
Coumarin-3-carboxylic acid (3-Carboxycoumarin) 是一种合成香豆素的重要起始化合物。其中香豆素是具有多种生物活性的天然产物。它的镧系复合物对 K-562 细胞具有抗增殖活性。 | |||
T2988 |
(-)-Epigallocatechin Gallate
Epigallocatechol Gallate,(-)-表没食子儿茶素没食子酸酯,EGCG |
Ferroptosis; Reactive Oxygen Species; HIV Protease; Mitochondrial Metabolism; Endogenous Metabolite; Autophagy | Apoptosis; Autophagy; Immunology/Inflammation; Metabolism; Microbiology/Virology; NF-κB; Proteases/Proteasome |
(-)-Epigallocatechin Gallate (EGCG) 是茶类黄酮,具有强大的抗氧化,抗炎和抗癌作用。它可抑制EGFR 信号传导,有抗癌作用。它是谷氨酸脱氢酶 1/2 抑制剂。它通过激活细胞色素c 氧化酶来诱导氧化磷酸化。 | |||
T2S0961 |
Chalcone
benzylideneacetophenone,phenyl styryl ketone,Cinnamophenone,benzalacetophenone,β-phenylacrylophenone,查耳酮 |
EGFR; Antibacterial | Angiogenesis; JAK/STAT signaling; Microbiology/Virology; Tyrosine Kinase/Adaptors |
Chalcone (Cinnamophenone) 是从甘草中分离得到的一种芳香酮,可合成查耳酮衍生物。它具有多种生物和药理的活性,如抗炎、抗菌、抗癌、抗氧化、抗寄生虫等活性。 | |||
T13126 |
Tephrosin
Deguelinol I,灰叶草素,Hydroxydeguelin |
Others | Others |
Tephrosin induces degradation of of EGFR and ErbB2 by inducing internalization of the receptors, has potent antitumor activities. | |||
T13559 |
Astragaloside VI
|
EGFR | Angiogenesis; JAK/STAT signaling; Tyrosine Kinase/Adaptors |
Astragaloside VI could improve wound healing by activating the EGFR/ERK signaling pathway. | |||
T2859 |
Biochanin A
4-Methylgenistein,鹰嘴豆芽素A,Olmelin |
EGFR; FAAH; Autophagy | Angiogenesis; Autophagy; JAK/STAT signaling; Metabolism; Neuroscience; Tyrosine Kinase/Adaptors |
Biochanin A (4-Methylgenistein) 是一种从红三叶车轴草中分离出来的异黄酮衍生物,具有抗癌特性。它是脂肪酸酰胺水解酶抑制剂,作用于小鼠、大鼠和人 FAAH,IC50分别为 1.8、1.4 和 2.4 μM。 | |||
TN3711 |
Corylifol C
|
ERK; EGFR; p38 MAPK; MEK | Angiogenesis; JAK/STAT signaling; MAPK; Tyrosine Kinase/Adaptors |
Corylifol C and, to a lesser extent, xanthoangelol are potent protein kinase inhibitors (inhibitory concentration 50% values for epidermal growth factor receptor (EGFR): 1.1 and 4.4 × 10(-6) μg/ml, respectively). | |||
TN2504 |
1,5-Dihydroxyxanthone
|
EGFR; AChR | Angiogenesis; JAK/STAT signaling; Neuroscience; Tyrosine Kinase/Adaptors |
1,5-Dihydroxyxanthone exhibits the epidermal growth factor receptor (EGFR) -tyrosine kinase inhibitory activity, with the IC50 value of 90.34 nM. It may have anticholinesterase activity on acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) enzym | |||
TN5100 |
Taspine
|
ERK; EGFR; BCL; VEGFR; MAPK; Akt | Angiogenesis; Apoptosis; Cytoskeletal Signaling; JAK/STAT signaling; MAPK; PI3K/Akt/mTOR signaling; Tyrosine Kinase/Adaptors |
Taspine shows antitumor activity by modulating the EGFR signaling pathway of Erk1/2 and Akt in vitro and in vivo, it can inhibit growth and induce apoptosis of HUVEC in a dose-dependent manner, it has shown meaningful angiogenesis activity. Taspine exhibi | |||
TN3525 |
Boehmenan
|
ERK; Phosphatase; EGFR; PARP; MEK; Wnt/beta-catenin; Akt; Caspase; STAT; p53 | Angiogenesis; Apoptosis; Chromatin/Epigenetic; Cytoskeletal Signaling; DNA Damage/DNA Repair; JAK/STAT signaling; MAPK; Metabolism; PI3K/Akt/mTOR signaling; Proteases/Proteasome; Stem Cells; Tyrosine Kinase/Adaptors |
(±)-Boehmenan shows potent protein-tyrosine phosphatase 1B (PTP1B) inhibitory activity in vitro with the IC(50) values of 43.5 uM, it inhibits PTP1B activity in a competitive manner. Boehmenan exhibits the potent cytotoxic effects against many cancer cell |
Cat. No. | Product Name | Species | Expression System |
---|---|---|---|
TMPY-00742 |
EGFR Protein, Human, Recombinant (His)
mENA,NISBD2,ERBB1,HER1,PIG61,ERBB,epidermal growth factor re... |
Human | HEK293 Cells |
EGFR Protein, Human, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 69.8 kDa and the accession number is P00533-1. | |||
TMPY-04818 |
EGFR Protein, Cynomolgus, Recombinant (His)
epidermal growth factor receptor |
Cynomolgus | HEK293 Cells |
EGFR Protein, Cynomolgus, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 70.1 kDa and the accession number is A0A2K5WK39. | |||
TMPY-02676 |
EGFR Protein, Mouse, Recombinant (His)
Errp,AI552599,Errb1,9030024J15Rik,wa2,Erbb,wa-2,Wa5,epiderma... |
Mouse | HEK293 Cells |
EGFR Protein, Mouse, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 70.8 kDa and the accession number is Q01279. | |||
TMPK-00426 |
EGFR Protein, Human, Recombinant (His & Avi)
PIG61,mENA,NISBD2,EC 2.7.10.1,HER1,EC 2.7.10,ERBB1,LEGFR... |
Human | HEK293 Cells |
EGFR Protein, Human, Recombinant (His & Avi) is expressed in HEK293 mammalian cells with C-His-Avi tag. The predicted molecular weight is 71.5 kDa and the accession number is P00533-1. | |||
TMPK-00902 |
EGFR Protein, Rhesus macaque, Recombinant (His)
HER1,EC 2.7.10,EGFR,NISBD2,ErbB,PIG61,ERBB1,LEG... |
Rhesus | HEK293 Cells |
EGFR Protein, Rhesus macaque, Recombinant (His) is expressed in HEK293 mammalian cells with C-His tag. The predicted molecular weight is 69.8 kDa and the accession number is P55245. | |||
TMPJ-00648 |
EGFR vIII Protein, Human, Recombinant (His)
EGFR,Proto-oncogene c-ErbB-1,Epidermal growth facto... |
Human | HEK293 Cells |
EGFR vIII Protein, Human, Recombinant (His) is expressed in HEK293 mammalian cells with C-6xHis tag. The predicted molecular weight is 61-75 Kda and the accession number is NP_001333870. | |||
TMPK-00425 |
EGFR Protein, Human, Recombinant (His & Avi), FITC-Labeled
EC 2.7.10.1,HER1,EGFR,PIG61,LEGFR,ErbB,ERB... |
Human | HEK293 Cells |
EGFR Protein, Human, Recombinant (His & Avi), FITC-Labeled is expressed in HEK293 mammalian cells with C-His-Avi tag. The predicted molecular weight is 71.5 kDa and the accession number is P00533-1. | |||
TMPJ-00647 |
EGFR vIII Protein, Human, Recombinant (hFc)
EGFR,Epidermal growth factor receptor,Proto-oncogen... |
Human | HEK293 Cells |
EGFR vIII Protein, Human, Recombinant (hFc) is expressed in HEK293 mammalian cells with C-Fc tag. The predicted molecular weight is 90-120 KDa and the accession number is NP_001333870. | |||
TMPK-00427 |
EGFR Protein, Human, Recombinant (His & Avi), Biotinylated
PIG61,ERBB,LEGFR,mENA,EC 2.7.10.1,EGFR,EC ... |
Human | HEK293 Cells |
EGFR Protein, Human, Recombinant (His & Avi), Biotinylated is expressed in HEK293 mammalian cells with C-His-Avi tag. The predicted molecular weight is 71.5 kDa and the accession number is P00533-1. | |||
TMPJ-00646 |
EGFR vIII Protein, Human, Recombinant (His & Avi), Biotinylated
Epidermal growth factor receptor,EGFR,Proto-oncogen... |
Human | HEK293 Cells |
EGFR vIII Protein, Human, Recombinant (His & Avi), Biotinylated is expressed in HEK293 mammalian cells with C-6xHis-Avi tag. The predicted molecular weight is 60-90 KDa and the accession number is NP_001333870. | |||
TMPY-04529 |
EGFR Protein, Human, Recombinant (aa 668-1210, His & GST)
epidermal growth factor receptor,PIG61,ERBB1,NISBD2,ERBB,HER... |
Human | Baculovirus Insect Cells |
EGFR Protein, Human, Recombinant (aa 668-1210, His & GST) is expressed in Baculovirus insect cells with His and GST tag. The predicted molecular weight is 89.1 kDa and the accession number is P00533-1. | |||
TMPK-01073 |
CLEC14A Protein, Human, Recombinant (His)
C14orf27,Epidermal growth factor receptor 5,UNQ236,EGFR<... |
Human | HEK293 Cells |
CLEC14A is a single-pass transmembrane glycoprotein belonging to the vascular expressed C-type lectin family. CLEC14A is found to be expressed in vascular endothelial cells during embryogenesis and is also implicated in tumor angiogenesis. | |||
TMPY-01043 |
EGFR Protein, Human, Recombinant (hFc)
ERBB,mENA,HER1,ERBB1,PIG61,NISBD2,epidermal growth factor re... |
Human | HEK293 Cells |
EGFR Protein, Human, Recombinant (hFc) is expressed in HEK293 mammalian cells with hFc tag. The predicted molecular weight is 95 kDa and the accession number is P00533-1. | |||
TMPK-00691 |
EGFRVIII Protein, Human, Recombinant (His & Avi)
EGFR,ErbB,mENA,HER1,LEGFR,EC 2.7.10.1,PIG6... |
Human | HEK293 Cells |
The epidermal growth factor receptor (EGFR) is overexpressed in a variety of human epithelial tumors, often as a consequence of gene amplification. Tumors with EGFR gene amplification frequently contain EGFR gene rearrangements, with the most common extracellular domain mutation being EGFRvIII. This mutation leads to a deletion of exons 2-7 of the EGFR gene and renders the mutant receptor incapable of binding any known ligand. EGFRVIII Protein, Human, Recombinant (His & Avi) is expressed in HEK2... | |||
TMPY-02958 |
EGFR Protein, Rat, Recombinant (His)
epidermal growth factor receptor |
Rat | HEK293 Cells |
EGFR Protein, Rat, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 70.7 kDa and the accession number is E7CXR8. | |||
TMPY-02675 |
EGFR Protein, Mouse, Recombinant (hFc)
Erbb,AI552599,wa-2,9030024J15Rik,Errp,wa2,Errb1,Wa5,epiderma... |
Mouse | HEK293 Cells |
EGFR Protein, Mouse, Recombinant (hFc) is expressed in HEK293 mammalian cells with hFc tag. The predicted molecular weight is 96 kDa and the accession number is Q01279. | |||
TMPY-03724 |
EGFR Protein, Canine, Recombinant (His)
epidermal growth factor receptor |
Canine | Baculovirus Insect Cells |
EGFR Protein, Canine, Recombinant (His) is expressed in Baculovirus insect cells with His tag. The predicted molecular weight is 69.8 kDa and the accession number is XP_533073.3. | |||
TMPY-06524 |
EGFR Protein, Feline, Recombinant (His)
epidermal growth factor receptor |
Feline | Baculovirus Insect Cells |
EGFR Protein, Feline, Recombinant (His) is expressed in Baculovirus insect cells with His tag. The predicted molecular weight is 70.18 kDa and the accession number is A0A337S424. | |||
TMPY-00128 |
EGFR Protein, Rhesus, Recombinant (hFc)
epidermal growth factor receptor |
Rhesus | HEK293 Cells |
EGFR Protein, Rhesus, Recombinant (hFc) is expressed in HEK293 mammalian cells with hFc tag. The predicted molecular weight is 95.4 kDa and the accession number is XP_001107305.1. | |||
TMPK-00689 |
EGFRVIII Protein, Human, Recombinant (His & Avi), PE-Labeled
EC 2.7.10.1,EC 2.7.10,ERBB1,EGFR,mENA,NISBD2,HER1,E... |
Human | HEK293 Cells |
The epidermal growth factor receptor (EGFR) is overexpressed in a variety of human epithelial tumors, often as a consequence of gene amplification. Tumors with EGFR gene amplification frequently contain EGFR gene rearrangements, with the most common extracellular domain mutation being EGFRvIII. This mutation leads to a deletion of exons 2-7 of the EGFR gene and renders the mutant receptor incapable of binding any known ligand. EGFRVIII Protein, Human, Recombinant (His & Avi), PE-Labeled is expre... | |||
TMPK-00690 |
EGFRVIII Protein, Human, Recombinant (His & Avi), FITC-Labeled
LEGFR,ERBB1,EGFR,HER1,PIG61,NISBD2,EC 2.7.... |
Human | HEK293 Cells |
The epidermal growth factor receptor (EGFR) is overexpressed in a variety of human epithelial tumors, often as a consequence of gene amplification. Tumors with EGFR gene amplification frequently contain EGFR gene rearrangements, with the most common extracellular domain mutation being EGFRvIII. This mutation leads to a deletion of exons 2-7 of the EGFR gene and renders the mutant receptor incapable of binding any known ligand. EGFRVIII Protein, Human, Recombinant (His & Avi), FITC-Labeled is exp... | |||
TMPK-00692 |
EGFRVIII Protein, Human, Recombinant (His & Avi), Biotinylated
EC 2.7.10.1,PIG61,NISBD2,HER1,mENA,LEGFR,ErbB,EC 2.... |
Human | HEK293 Cells |
The epidermal growth factor receptor (EGFR) is overexpressed in a variety of human epithelial tumors, often as a consequence of gene amplification. Tumors with EGFR gene amplification frequently contain EGFR gene rearrangements, with the most common extracellular domain mutation being EGFRvIII. This mutation leads to a deletion of exons 2-7 of the EGFR gene and renders the mutant receptor incapable of binding any known ligand. EGFRVIII Protein, Human, Recombinant (His & Avi), Biotinylated is exp... | |||
TMPY-05258 |
EGFR Protein, Human, Recombinant (Isoform Viii, hFc)
NISBD2,epidermal growth factor receptor,ERBB,PIG61,mENA,ERBB... |
Human | Baculovirus Insect Cells |
EGFR Protein, Human, Recombinant (Isoform Viii, hFc) is expressed in Baculovirus insect cells with hFc tag. The predicted molecular weight is 65.1 kDa and the accession number is NP_001333870.1. | |||
TMPY-06593 |
EGFR Protein, Human, Recombinant (Isoform vIII, His & Avi), Biotinylated
PIG61,ERBB1,ERBB,NISBD2,epidermal growth factor receptor,HER... |
Human | HEK293 Cells |
EGFR Protein, Human, Recombinant (Isoform vIII, His & Avi), Biotinylated is expressed in HEK293 mammalian cells with His and Avi tag. The predicted molecular weight is 41.90 kDa and the accession number is NP_001333870.1. | |||
TMPY-05211 |
EGFR Protein, Human, Recombinant (Isoform vIII, aa 1-375, His)
NISBD2,PIG61,ERBB,mENA,epidermal growth factor receptor,HER1... |
Human | Baculovirus Insect Cells |
EGFR Protein, Human, Recombinant (Isoform vIII, aa 1-375, His) is expressed in Baculovirus insect cells with His tag. The predicted molecular weight is 39.3 kDa and the accession number is NP_001333870.1. | |||
TMPY-05612 |
EGFR Protein, Human, Recombinant (aa 1-645, His & Avi), Biotinylated
mENA,PIG61,HER1,ERBB1,ERBB,NISBD2,epidermal growth factor re... |
Human | HEK293 Cells |
EGFR Protein, Human, Recombinant (aa 1-645, His & Avi), Biotinylated is expressed in HEK293 mammalian cells with His and Avi tag. The predicted molecular weight is 71.9 kDa and the accession number is P00533-1. | |||
TMPY-06549 |
EGFR Protein, Human, Recombinant (Isoform vIII, aa 1-378, His)
ERBB,epidermal growth factor receptor,HER1,mENA,ERBB1,PIG61,... |
Human | HEK293 Cells |
EGFR Protein, Human, Recombinant (Isoform vIII, aa 1-378, His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 40.09 kDa and the accession number is NP_001333870.1. | |||
TMPY-05637 |
EGFR Protein, Human, Recombinant (aa 1-378, His & Avi), Biotinylated
epidermal growth factor receptor,HER1,mENA,ERBB1,ERBB,NISBD2... |
Human | Baculovirus Insect Cells |
EGFR Protein, Human, Recombinant (aa 1-378, His & Avi), Biotinylated is expressed in Baculovirus insect cells with His and Avi tag. The predicted molecular weight is 41.8 kDa and the accession number is NP_001333870.1. | |||
TMPK-00429 |
HER2/ERBB2 Domain 4 Protein, Human, Recombinant (His & Avi)
HERV7Q,HER-2,HER2,NGL,EGFR2,ENVW,NEU,MLN 19,HERVW,C... |
Human | HEK293 Cells |
HER2/ERBB2 Domain 4 Protein, Human, Recombinant (His & Avi) is expressed in HEK293 mammalian cells with C-His-Avi tag. The predicted molecular weight is 18.5 kDa and the accession number is P04626-1. | |||
TMPK-00428 |
HER2/ErbB2 Protein, Human, Recombinant (His & Avi)
MLN 19,HER2,HER-2,HERVW,EGFR2,ENV,ERBB2,NEU,HERV7Q,... |
Human | HEK293 Cells |
ErbB2, also called Neu and Her2 (human epidermal growth factor receptor 2), is a type I membrane glycoprotein that is a member of the ErbB family of tyrosine kinase receptors. ErbB family members serve as receptors for the epidermal growth factor (EGF) family of growth factors.Upon ERBB2 activation, the MEMO1-RHOA-DIAPH1 signaling pathway elicits the phosphorylation and thus the inhibition of GSK3B at cell membrane. | |||
TMPK-00430 |
HER2/ERBB2 Domain 4 Protein, Human, Recombinant (His & Avi), Biotinylated
MLN19,HERV7Q,HERVW,MLN 19,TKR1,herstatin,ENVW,EGFR2... |
Human | HEK293 Cells |
HER2/ERBB2 Domain 4 Protein, Human, Recombinant (His & Avi), Biotinylated is expressed in HEK293 mammalian cells with C-His-Avi tag. The predicted molecular weight is 18.5 kDa and the accession number is P04626-1. | |||
TMPY-02361 |
VEGFR2/KDR Protein, Human, Recombinant (His)
VEGFR2,kinase insert domain receptor,VEGFR... |
Human | HEK293 Cells |
VEGFR2/KDR Protein, Human, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 84.6 kDa and the accession number is P35968-1. | |||
TMPJ-00412 |
VEGFR1/FLT-1 Protein, Human, Recombinant (hFc)
Vascular endothelial growth factor receptor 1,Vascular perme... |
Human | HEK293 Cells |
Human Vascular endothelial growth factor receptor 1(VEGFR-1, FLT-1) is a member of the the class III subfamily of receptor tyrosine kinases (RTKs) and Tyr protein kinase family and CSF-1/PDGF receptor subfamily. VEGFR-1 is widely expressed in human tissues including normal lung, placenta, liver, kidney, heart and brain tissues. It is specifically expressed in most of the vascular endothelial cellsand peripheral blood monocytes. VEGFR-1 contains seven Ig-like C2-type domains and one protein kinas... | |||
TMPY-01936 |
VEGFR3/FLT4 Protein, Mouse, Recombinant (His)
Flt-4,VEGFR-3,Chy,fms related tyrosine kinase 4,V |
Mouse | HEK293 Cells |
VEGFR3/FLT4 Protein, Mouse, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 86.4 kDa and the accession number is P35917-1. | |||
TMPY-00949 |
VEGFR3/FLT4 Protein, Human, Recombinant (His)
VEGFR-3,PCL,FLT41,VEGF Receptor 3,VEGFR3,F... |
Human | HEK293 Cells |
VEGFR3/FLT4 Protein, Human, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 86 kDa and the accession number is P35916-1. | |||
TMPK-00451 |
VEGFR1/FLT-1 Protein, Human, Recombinant (His & Avi), Biotinylated
FLT,Flt-1,FRT,VEGFR1,VEGF R1,FLT1 |
Human | HEK293 Cells |
VEGFR1/FLT-1 Protein, Human, Recombinant (His & Avi), Biotinylated is expressed in HEK293 mammalian cells with C-His-Avi tag. The predicted molecular weight is 85.1 kDa and the accession number is P17948-1. | |||
TMPK-00445 |
VEGFR3/FLT4 Protein, Human, Recombinant (His & Avi)
PCL,PCLFLT41,VEGFR3,FLT-4,LMPH1A,FLT-41,VEGFR |
Human | HEK293 Cells |
Vascular endothelial growth factor (VEGF) and its receptors VEGF-R1, -R2 and -R3 play important roles in tumor angiogenesis and are associated with poor prognosis in several solid tumors.VEGF-R1, -R2 and -R3 were highly expressed in CRC cells and stromal vessels. VEGF-R1 strong positive staining correlated with shorter survival after CRC surgery. VEGFR3/FLT4 Protein, Human, Recombinant (His & Avi) is expressed in HEK293 mammalian cells with C-His-Avi tag. The predicted molecular weight is 87.4 k... | |||
TMPY-04796 |
VEGFR2/KDR Protein, Human, Recombinant (Domain 2&3, His)
FLK1,kinase insert domain receptor,CD309,VEGFR2,Flk... |
Human | HEK293 Cells |
VEGFR2/KDR Protein, Human, Recombinant (Domain 2&3, His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 24.8 kDa and the accession number is P35968-1. | |||
TMPY-02736 |
VEGFR2/KDR Protein, Mouse, Recombinant (His)
sVEGFR-2,6130401C07,kinase insert domain receptor,V... |
Mouse | HEK293 Cells |
VEGFR2/KDR Protein, Mouse, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 84.5 kDa and the accession number is P35918-1. | |||
TMPY-02858 |
VEGFR2/KDR Protein, Mouse, Recombinant (hFc)
VEGFR2,6130401C07,Krd-1,kinase insert domain recept... |
Mouse | HEK293 Cells |
VEGFR2/KDR Protein, Mouse, Recombinant (hFc) is expressed in HEK293 mammalian cells with hFc tag. The predicted molecular weight is 110 kDa and the accession number is P35918. | |||
TMPY-04530 |
VEGFR2/KDR Protein, Human, Recombinant (His & GST)
Flk-1,VEGFR2,kinase insert domain receptor,FLK1,CD3... |
Human | Baculovirus Insect Cells |
VEGFR2/KDR Protein, Human, Recombinant (His & GST) is expressed in Baculovirus insect cells with His and GST tag. The predicted molecular weight is 89.3 kDa and the accession number is P35968-1. | |||
TMPK-00454 |
VEGFR2/KDR Protein, Human, Recombinant (His & Avi)
VEGFR-21,Ly73,KRD1,VEGFR2,CD309,FLK1,V... |
Human | HEK293 Cells |
Tyrosine-protein kinase that acts as a cell-surface receptor for VEGFA, VEGFB and PGF, and plays an essential role in the development of embryonic vasculature, the regulation of angiogenesis, cell survival, cell migration, macrophage function, chemotaxis, and cancer cell invasion. The tyrosine kinase receptor vascular endothelial growth factor receptor 2 (VEGFR2) is a key regulator of angiogenesis. VEGFR2/KDR Protein, Human, Recombinant (His & Avi) is expressed in HEK293 mammalian cells with C-H... | |||
TMPY-01937 |
VEGFR3/FLT4 Protein, Mouse, Recombinant (hFc)
VEGFR-3,fms related tyrosine kinase 4,VEGFR |
Mouse | HEK293 Cells |
VEGFR3/FLT4 Protein, Mouse, Recombinant (hFc) is expressed in HEK293 mammalian cells with hFc tag. The predicted molecular weight is 112 kDa and the accession number is P35917-1. | |||
TMPJ-00414 |
VEGFR2/KDR Protein, Human, Recombinant (aa 20-764, His & Avi), Biotinylated
Protein-tyrosine kinase receptor flk-1,KDR,Kinase insert dom... |
Human | HEK293 Cells |
VEGFR2/KDR Protein, Human, Recombinant (aa 20-764, His & Avi), Biotinylated is expressed in HEK293 mammalian cells with C-6xHis-Avi tag. The predicted molecular weight is 120-150 KDa and the accession number is P35968. | |||
TMPY-04940 |
VEGFR2/KDR Protein, Human, Recombinant (His), Biotinylated
Flk-1,kinase insert domain receptor,VEGFR,CD309,V |
Human | HEK293 Cells |
VEGFR2/KDR Protein, Human, Recombinant (His), Biotinylated is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 84.6 kDa and the accession number is P35968-1. | |||
TMPK-00450 |
VEGFR1/FLT-1 Protein, Human, Recombinant (His & Avi)
FLT1,FRT,FLT,Flt-1,VEGF R1,VEGFR1 |
Human | HEK293 Cells |
VEGFR1/FLT-1 Protein, Human, Recombinant (His & Avi) is expressed in HEK293 mammalian cells with C-His-Avi tag. The predicted molecular weight is 85.1 kDa and the accession number is P17948-1. | |||
TMPK-00446 |
VEGFR3/FLT4 Protein, Human, Recombinant (aa 25-776, His & Avi), Biotinylated
PCL,FLT-41,LMPH1A,FLT-4,VEGFR3,PCLFLT41,VEGFR |
Human | HEK293 Cells |
Vascular endothelial growth factor (VEGF) and its receptors VEGF-R1, -R2 and -R3 play important roles in tumor angiogenesis and are associated with poor prognosis in several solid tumors.VEGF-R1, -R2 and -R3 were highly expressed in CRC cells and stromal vessels. VEGF-R1 strong positive staining correlated with shorter survival after CRC surgery. VEGFR3/FLT4 Protein, Human, Recombinant (aa 25-776, His & Avi), Biotinylated is expressed in HEK293 mammalian cells with C-His-Avi tag. The predicted m... | |||
TMPY-01069 |
VEGFR3/FLT4 Protein, Human, Recombinant (hFc)
FLT41,fms related tyrosine kinase 4,VEGF Receptor 3,PCL,FLT-... |
Human | HEK293 Cells |
VEGFR3/FLT4 Protein, Human, Recombinant (hFc) is expressed in HEK293 mammalian cells with hFc tag. The predicted molecular weight is 111.3 kDa and the accession number is P35916-1. | |||
TMPY-04802 |
VEGFR2/KDR Protein, Human, Recombinant (Domain 2&3, hFc)
kinase insert domain receptor,CD309,VEGFR2,FLK1,Flk... |
Human | HEK293 Cells |
VEGFR2/KDR Protein, Human, Recombinant (Domain 2&3, hFc) is expressed in HEK293 mammalian cells with hFc tag. The predicted molecular weight is 50.4 kDa and the accession number is P35968-1. | |||
TMPY-05610 |
VEGFR2/KDR Protein, Human, Recombinant (His & Avi), Biotinylated
Flk-1,VEGFR,kinase insert domain receptor,VEGFR... |
Human | HEK293 Cells |
VEGFR2/KDR Protein, Human, Recombinant (His & Avi), Biotinylated is expressed in HEK293 mammalian cells with His and Avi tag. The predicted molecular weight is 86.5 kDa and the accession number is P35968-1. | |||
------------------------ 更多 ------------------------ |